The Reuters report on a head-to-head trial against tirzepatide (February 2026) noted CagriSema did not meet a non-inferiority threshold against tirzepatide on average weight loss at 84 weeks
The Mechanism: The Hyperexcitable Brain The migraine brain is genetically distinct
BPC 157 does not directly increase growth hormone but may support healing and regeneration
Crosses the Blood-Brain Barrier Unlike many peptides and growth factors, Dihexa is orally bioavailable and crosses the BBB , meaning it can be taken as an oral tablet and still reach brain tissues in therapeutic concentrations
Its not just that AOD9604 is hard to make (although it is), but also that its a very specific modified fragment
Supplies Reconstituted vial, BAC water, U-100 syringes, alcohol swabs, calculator for unit math